HSA Reclassified Drug | Exemptions For Supply of Bromhexine Tablet Without Prescription


Eligible Active Ingredient: Bromhexine Tablet. As an oral solid preparation containing not more than 8mg
With Effective From: 1-Jul-2011
Indication Permitted: To clear the chest by thinning the mucus in air passages
Maximum Daily Dose: Criteria Not Specified
Maximum Supply per Transaction: Criteria Not Specified
Minimum Age of User: Criteria Not Specified
Patient Information Leaflet from HSA/PSS: Download PIL (Link to HSA website)

Mechanism of Action of Bromhexine Tablet

Not Available At The Moment.

Additional Information of Bromhexine Tablet

Pharmacology Class: Expectorants, excluding Combinations With Cough Suppressants
Therapeutic Class: Cough And Cold Preparations
Chemical Class: Mucolytics
Synonyms: 3,5-Dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha-2-diamine | Bromexina | Bromhexina | Bromhexinum | Fluibron | N-Cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amine | Tauglicolo

Show All HSA-registered therapeutic products granted exemption to supply without prescription


  1. Health Science Authority of Singapore – Reclassified POM
  2. Drugbank

HSA-Registered Products Containing Bromhexine Tablet As an oral solid preparation containing not more than 8mg

wpDataTable with provided ID not found!

This list is not exhaustive. HSA collaborates with Pharmaceurical Society of Singapore (PSS) to review the appropriate use of therapeutic products in the community from time to time. Hence, HSA may enable the supply of a Prescription Only Medicine (POM) by pharmacists without a prescription, upon review that the product can be used in a safe and effective manner under the supervision of a pharmacist. This can be effected through legislative mechanisms in the absence of an application made by the product registrant to reclassify the therapeutic product, subject to to conditions including indication, strength, maximum daily dose, maximum supply quantity, and age restriction.